The role of fibrosis, inflammation, and congestion biomarkers for outcome prediction in candidates to cardiac resynchronization therapy: is “response” the right answer?

BACKGROUND: Cardiac resynchronization therapy (CRT) is an established treatment in selected patients suffering from heart failure with reduced ejection fraction (HFrEF). It has been proposed that myocardial fibrosis and inflammation could influence CRT “response” and outcome. Our study investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Beltrami, Matteo, Galluzzo, Alessandro, Brocci, Riccardo Tappa, Paoletti Perini, Alessandro, Pieragnoli, Paolo, Garofalo, Manuel, Halasz, Geza, Milli, Massimo, Barilli, Maria, Palazzuoli, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291081/
https://www.ncbi.nlm.nih.gov/pubmed/37378403
http://dx.doi.org/10.3389/fcvm.2023.1180960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291081/
https://www.ncbi.nlm.nih.gov/pubmed/37378403
http://dx.doi.org/10.3389/fcvm.2023.1180960

Ejemplares similares